source
- Capricor boosts manufacturing capacity as FDA decision on DMD cell therapy loomsCapricor Therapeutics, a biotech developing a cell therapy for Duchenne muscular dystrophy, is preparing for an FDA decision expected by late November. The company’s third-quarter operating expens…
- Study warns German drug price hikes could raise US Medicaid spending by $300 millionA new Harvard Medical School study examined the effect of Germany's drug price increases on the United States under President Trump's most‑favored‑nation policy, which ties US federal drug pricing…